Ingenuity Canonical Pathways, -log(p-value),zScore,Ratio,Molecules
1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian),-0,,0.0556,SYNJ2
Actin Nucleation by ARP-WASP Complex,-0,,0.0556,"BAIAP2,ITGB1,RALB,RHOBTB1"
Allograft Rejection Signaling,-0,,0.0465,"HLA-B,HLA-C,HLA-DPB1,HLA-DQA2"
Angiopoietin Signaling,-0,,0.0533,"BIRC5,PIK3C2A,PIK3CD,RALB"
Apelin Muscle Signaling Pathway,-0,,0.0526,PRKAA1
Apoptosis Signaling,-0,,0.0303,"BCL2A1,CAPN7,RALB"
Aryl Hydrocarbon Receptor Signaling,-0,0,0.035,"ALDH3B1,CDKN2A,MYC,RARA,RBL2"
Autoimmune Thyroid Disease Signaling,-0,,0.0408,"HLA-B,HLA-C"
B Cell Development,-0,,0.0556,"HLA-B,IL7"
Basal Cell Carcinoma Signaling,-0,,0.0556,"BMP6,FZD1,FZD2,WNT16"
Bupropion Degradation,-0,,0.04,POR
CD27 Signaling in Lymphocytes,-0,,0.0566,"MAP3K11,MAPK10,MAPK12"
Calcium-induced T Lymphocyte Apoptosis,-0,,0.0455,"CALM1 (includes others),HLA-B,PRKCD"
Cancer Drug Resistance By Drug Efflux,-0,,0.0517,"ABCB1,PIK3CD,RALB"
Cardiomyocyte Differentiation via BMP Receptors,-0,,0.05,BMPR1A
Cell Cycle: G1/S Checkpoint Regulation,-0,-2,0.0597,"CDKN2A,HDAC4,MYC,RBL2"
Cell Cycle: G2/M DNA Damage Checkpoint Regulation,-0,,0.0408,"CCNB1,CDKN2A"
Clathrin-mediated Endocytosis Signaling,-0,,0.0518,"AMPH,AP1B1,ARRB2,EPHB2,ITGB1,ORM2,PIK3C2A,PIK3CD,S100A8,VEGFA"
Cyclins and Cell Cycle Regulation,-0,,0.0494,"CCNB1,CDKN2A,HDAC4,PPP2R3A"
Cysteine Biosynthesis III (mammalia),-0,,0.0417,PRMT5
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells,-0,,0.0588,"HLA-B,HLA-C"
"D-myo-inositol (1,3,4)-trisphosphate Biosynthesis",-0,,0.0556,SYNJ2
DNA Methylation and Transcriptional Repression Signaling,-0,,0.0286,H3-3A/H3-3B
DNA damage-induced 14-3-3? Signaling,-0,,0.0526,CCNB1
Death Receptor Signaling,-0,,0.022,"PARP9,TNFSF10"
Dermatan Sulfate Degradation (Metazoa),-0,,0.0588,HEXD
Dopamine Receptor Signaling,-0,,0.0519,"ADCY1,NCS1,PPP2R3A,PRKAR1B"
Dopamine-DARPP32 Feedback in cAMP Signaling,-0,-0.707106781,0.0552,"ADCY1,CALM1 (includes others),CREB5,KCNJ15,PLCB1,PLCD3,PPP2R3A,PRKAR1B,PRKCD"
EIF2 Signaling,-0,-0.377964473,0.0357,"DDIT3,IGF1R,MYC,PIK3C2A,PIK3CD,RALB,SREBF1,VEGFA"
Endoplasmic Reticulum Stress Pathway,-0,,0.0476,DDIT3
ErbB4 Signaling,-0,1,0.0597,"PIK3C2A,PIK3CD,PRKCD,RALB"
Estrogen Biosynthesis,-0,,0.0244,POR
Estrogen-mediated S-phase Entry,-0,,0.0385,MYC
FAT10 Cancer Signaling Pathway,-0,,0.0435,"ACVR1,ACVR1B"
Fatty Acid ?-oxidation,-0,,0.05,ALDH3B1
GABA Receptor Signaling,-0,,0.0526,"ADCY1,AP1B1,CACNA1F,CACNA2D4,CACNG6"
Glutathione-mediated Detoxification,-0,,0.0312,LANCL1
Granzyme A Signaling,-0,,0.0526,ANP32A
HIPPO signaling,-0,,0.0471,"PPP2R3A,RASSF1,RASSF6,SMAD1"
Hematopoiesis from Pluripotent Stem Cells,-0,,0.0408,"CSF1,IL7"
Histamine Degradation,-0,,0.0588,ALDH3B1
IL-2 Signaling,-0,,0.0492,"PIK3C2A,PIK3CD,RALB"
Induction of Apoptosis by HIV1,-0,,0.0328,"MAPK10,MAPK12"
Lipid Antigen Presentation by CD1,-0,,0.0385,AP1B1
Mechanisms of Viral Exit from Host Cells,-0,,0.0488,"LMNB1,PRKCD"
Melatonin Degradation I,-0,,0.05,"POR,SULT1A3/SULT1A4,SULT1B1"
Methionine Degradation I (to Homocysteine),-0,,0.0455,PRMT5
Mitochondrial Dysfunction,-0,,0.0585,"APP,GLRX2,MAPK10,MAPK12,MT-ATP6,MT-CO1,MT-CO2,MT-CO3,MT-ND3,MT-ND4"
Mitotic Roles of Polo-Like Kinase,-0,,0.0455,"CCNB1,CDC7,PPP2R3A"
NER Pathway,-0,,0.0388,"ERCC6,H3-3A/H3-3B,POLD4,UBE2N"
Neuregulin Signaling,-0,,0.0417,"ITGB1,MYC,PRKCD,RALB"
Neuropathic Pain Signaling In Dorsal Horn Neurons,-0,0,0.0594,"PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKAR1B,PRKCD"
Nicotine Degradation II,-0,,0.0154,POR
Nicotine Degradation III,-0,,0.0179,POR
Noradrenaline and Adrenaline Degradation,-0,,0.0571,"AKR1A1,ALDH3B1"
Nucleotide Excision Repair Pathway,-0,,0.0286,ERCC6
Nur77 Signaling in T Lymphocytes,-0,,0.0339,"CALM1 (includes others),HLA-B"
Oxidative Phosphorylation,-0,-2.449489743,0.055,"MT-ATP6,MT-CO1,MT-CO2,MT-CO3,MT-ND3,MT-ND4"
PPAR Signaling,-0,,0.0288,"IL1RN,RALB,TRAF6"
Phagosome Maturation,-0,,0.0596,"CTSA,CTSG,CYBB,HLA-B,HLA-C,NCF1,TUBA1A,TUBA1C,TUBE1"
Phototransduction Pathway,-0,,0.0189,PRKAR1B
Primary Immunodeficiency Signaling,-0,,0.04,"IGLL1/IGLL5,RFXAP"
Prostate Cancer Signaling,-0,,0.044,"CREB5,PIK3C2A,PIK3CD,RALB"
RAN Signaling,-0,,0.0588,RANGAP1
Regulation of Actin-based Motility by Rho,-0,,0.0426,"BAIAP2,ITGB1,MYL5,RHOBTB1"
Renal Cell Carcinoma Signaling,-0,,0.05,"PIK3C2A,PIK3CD,RALB,VEGFA"
Retinoate Biosynthesis I,-0,,0.0294,RDH10
Retinol Biosynthesis,-0,,0.0238,RDH10
Role of CHK Proteins in Cell Cycle Checkpoint Control,-0,,0.0175,PPP2R3A
Role of Cytokines in Mediating Communication between Immune Cells,-0,,0.0556,"IL1RN,IL23A,IL27"
Role of Oct4 in Mammalian Embryonic Stem Cell Pluripotency,-0,,0.0435,"MEF2A,RARA"
Role of PI3K/AKT Signaling in the Pathogenesis of Influenza,-0,,0.0469,"CCL5,PIK3C2A,PIK3CD"
Role of Wnt/GSK-3? Signaling in the Pathogenesis of Influenza,-0,,0.0385,"FZD1,FZD2,WNT16"
SPINK1 Pancreatic Cancer Pathway,-0,,0.0333,"CTSA,PRSS1"
Serotonin Degradation,-0,2,0.0597,"AKR1A1,ALDH3B1,SULT1A3/SULT1A4,SULT1B1"
Serotonin Receptor Signaling,-0,,0.0233,ADCY1
Small Cell Lung Cancer Signaling,-0,,0.0563,"MYC,PIK3C2A,PIK3CD,TRAF6"
Superpathway of Melatonin Degradation,-0,,0.0462,"POR,SULT1A3/SULT1A4,SULT1B1"
Superpathway of Methionine Degradation,-0,,0.027,PRMT5
Telomerase Signaling,-0,1.341640786,0.0561,"HDAC4,MYC,PIK3C2A,PIK3CD,PPP2R3A,RALB"
The Visual Cycle,-0,,0.05,RDH10
Thyroid Hormone Metabolism II (via Conjugation and/or Degradation),-0,,0.0526,"SULT1A3/SULT1A4,SULT1B1"
Tight Junction Signaling,-0,,0.0536,"CEBPA,CPSF6,JAM3,MYH7B,MYL5,OCLN,PPP2R3A,PRKAR1B,TIAM1"
Triacylglycerol Degradation,-0,,0.0426,"MGLL,PNPLA7"
Vitamin-C Transport,-0,,0.0417,SLC2A3
Xenobiotic Metabolism CAR Signaling Pathway,-0,-0.377964473,0.037,"ABCB1,ALDH3B1,PPP2R3A,PRKCD,SULT1A3/SULT1A4,SULT1B1,UST"
Xenobiotic Metabolism PXR Signaling Pathway,-0,0.377964473,0.0365,"ABCB1,ALDH3B1,PRKAR1B,PRKCD,SULT1A3/SULT1A4,SULT1B1,UST"
Xenobiotic Metabolism Signaling,-0,,0.0557,"ABCB1,ALDH3B1,HDAC4,HMOX1,MAP3K11,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,PPP2R3A,PRKCD,RALB,SULT1A3/SULT1A4,SULT1B1,UST"
tRNA Splicing,-0,,0.0465,"PDE9A,SMPDL3A"
Chondroitin Sulfate Degradation (Metazoa),0.202,,0.0625,HEXD
Granzyme B Signaling,0.202,,0.0625,LMNB1
Adenosine Nucleotides Degradation II,0.219,,0.0667,ACPP
Circadian Rhythm Signaling,0.225,,0.0606,"CREB5,CRY1"
Myc Mediated Apoptosis Signaling,0.235,,0.06,"CDKN2A,MYC,PRKAR1B"
"Phenylalanine Degradation IV (Mammalian, via Side Chain)",0.238,,0.0714,SLC27A3
Graft-versus-Host Disease Signaling,0.256,,0.0625,"HLA-B,HLA-C,IL1RN"
"Bile Acid Biosynthesis, Neutral Pathway",0.258,,0.0769,HSD3B7
Glucocorticoid Biosynthesis,0.258,,0.0769,HSD3B7
Oleate Biosynthesis II (Animals),0.258,,0.0769,SCD
ErbB2-ErbB3 Signaling,0.259,1,0.0615,"MYC,PIK3C2A,PIK3CD,RALB"
Pyridoxal 5'-phosphate Salvage Pathway,0.259,1,0.0615,"DAPK1,LIMK2,PRKAA1,PRKCD"
Regulation of Cellular Mechanics by Calpain Protease,0.259,,0.0615,"ACTN1,CAPN7,ITGB1,RALB"
NF-?B Activation by Viruses,0.261,0.447213595,0.061,"ITGB1,PIK3C2A,PIK3CD,PRKCD,RALB"
VEGF Signaling,0.262,0.816496581,0.0606,"ACTN1,PIK3C2A,PIK3CD,PTPN6,RALB,VEGFA"
Acetone Degradation I (to Methylglyoxal),0.265,,0.0667,"POR,ZADH2"
Cellular Effects of Sildenafil (Viagra),0.277,,0.0611,"ADCY1,CACNG6,CALM1 (includes others),MYH7B,MYL5,PLCB1,PLCD3,PRKAR1B"
Systemic Lupus Erythematosus In T Cell Signaling Pathway,0.279,-0.447213595,0.0601,"BCL6,CASP1,CASP4,CASP5,CREB5,HLA-B,HLA-C,HLA-DPB1,HLA-DQA2,ICOSLG/LOC102723996,IL23A,IRF4,PIK3C2A,PIK3CD,PPP2R3A,RALB,RHOBTB1,RORC,S1PR3,YES1"
Gap Junction Signaling,0.28,,0.0606,"ADCY1,DBN1,GRIK1,PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKAR1B,PRKCD,RALB,TUBA1A,TUBA1C"
Assembly of RNA Polymerase I Complex,0.281,,0.0833,TAF1A
Cleavage and Polyadenylation of Pre-mRNA,0.281,,0.0833,CPSF6
Guanosine Nucleotides Degradation III,0.281,,0.0833,ACPP
Mineralocorticoid Biosynthesis,0.281,,0.0833,HSD3B7
NAD biosynthesis II (from tryptophan),0.281,,0.0833,HAAO
FAK Signaling,0.296,,0.0632,"CAPN7,DOCK1,ITGB1,PIK3C2A,PIK3CD,RALB"
Heparan Sulfate Biosynthesis,0.298,1.341640786,0.0641,"EXT1,PNPLA7,SULT1A3/SULT1A4,SULT1B1,UST"
Autophagy,0.301,,0.0656,"CTSA,CTSG,ULK1,WDFY3"
iCOS-iCOSL Signaling in T Helper Cells,0.302,0.377964473,0.0631,"CALM1 (includes others),GAB2,HLA-B,ICOSLG/LOC102723996,NFATC3,PIK3C2A,PIK3CD"
Purine Nucleotides De Novo Biosynthesis II,0.307,,0.0909,IMPDH1
mTOR Signaling,0.309,1.897366596,0.0619,"HMOX1,IRS1,PIK3C2A,PIK3CD,PLD3,PPP2R3A,PRKAA1,PRKCD,PRR5L,RALB,RHOBTB1,ULK1,VEGFA"
HOTAIR Regulatory Pathway,0.309,0.333333333,0.0625,"CDH1,H3-3A/H3-3B,MEX3B,MMP25,MTF2,MYC,PIK3C2A,PIK3CD,TLR4,WNT16"
Xenobiotic Metabolism General Signaling Pathway,0.312,2.333333333,0.0629,"HMOX1,MAP3K11,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,PRKCD,RALB"
Retinoic acid Mediated Apoptosis Signaling,0.313,2,0.0667,"PARP9,RARA,TNFRSF10D,TNFSF10"
Semaphorin Signaling in Neurons,0.313,,0.0667,"FES,ITGB1,LIMK2,RHOBTB1"
Atherosclerosis Signaling,0.315,,0.0635,"ALOX5,COL18A1,CSF1,IL1RN,ORM2,PLA2G4B,PLAAT5,S100A8"
PTEN Signaling,0.315,-0.707106781,0.0635,"BMPR1A,IGF1R,ITGB1,MAGIX,MCRS1,PIK3CD,RALB,SYNJ2"
Oncostatin M Signaling,0.319,,0.0698,"EPAS1,JAK2,RALB"
Pyrimidine Ribonucleotides De Novo Biosynthesis,0.319,,0.0698,"CMPK2,ENTPD1,NME7"
Gluconeogenesis I,0.331,,0.0769,"FBP1,ME1"
Glycolysis I,0.331,,0.0769,"FBP1,PFKM"
NAD Salvage Pathway II,0.331,,0.0769,"ACPP,PXYLP1"
Triacylglycerol Biosynthesis,0.334,,0.0714,"AGPAT2,AGPAT3,GPAM"
Insulin Receptor Signaling,0.336,0.333333333,0.0643,"IRS1,JAK2,PIK3C2A,PIK3CD,PRKAR1B,RALB,SCNN1A,SOCS3,SYNJ2"
Calcium Transport I,0.337,,0.1,ATP2C2
Glycine Betaine Degradation,0.337,,0.1,PIPOX
Pentose Phosphate Pathway,0.337,,0.1,PGD
Estrogen-Dependent Breast Cancer Signaling,0.34,1.341640786,0.0676,"CREB5,IGF1R,PIK3C2A,PIK3CD,RALB"
Glioma Invasiveness Signaling,0.34,0,0.0676,"PIK3C2A,PIK3CD,RALB,RHOBTB1,TIMP2"
PKC? Signaling in T Lymphocytes,0.347,1.133893419,0.0645,"CACNA1F,CACNA2D4,CACNG6,HLA-B,MAP3K11,NFATC3,PIK3C2A,PIK3CD,RALB,VAV2"
Pyrimidine Ribonucleotides Interconversion,0.349,,0.0732,"CMPK2,ENTPD1,NME7"
CNTF Signaling,0.35,1,0.0702,"JAK2,PIK3C2A,PIK3CD,RALB"
Glutamate Receptor Signaling,0.35,,0.0702,"CALM1 (includes others),GNG2,GRIK1,HOMER3"
"D-myo-inositol (1,4,5)-Trisphosphate Biosynthesis",0.351,,0.08,"PLCB1,PLCD3"
"Tryptophan Degradation X (Mammalian, via Tryptamine)",0.351,,0.08,"AKR1A1,ALDH3B1"
Non-Small Cell Lung Cancer Signaling,0.352,0,0.0685,"CDKN2A,PIK3C2A,PIK3CD,RALB,RASSF1"
Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes,0.354,,0.0674,"CALM1 (includes others),MAPK10,MAPK12,NFATC3,RALB,VAV2"
T Cell Receptor Signaling,0.356,,0.0667,"CALM1 (includes others),NFATC3,PIK3C2A,PIK3CD,PTPN7,RALB,VAV2"
Cell Cycle Control of Chromosomal Replication,0.363,-1,0.0714,"CDC7,CDK14,ORC2,ORC4"
Chondroitin Sulfate Biosynthesis,0.363,0,0.0714,"CHPF,SULT1A3/SULT1A4,SULT1B1,UST"
ERK5 Signaling,0.363,1.341640786,0.0694,"CREB5,ELK4,MEF2A,MYC,RALB"
Ceramide Signaling,0.364,0,0.0682,"PIK3C2A,PIK3CD,PPP2R3A,RALB,S1PR1,S1PR3"
Protein Kinase A Signaling,0.366,0,0.0628,"ADCY1,AKAP5,CALM1 (includes others),CREB5,DUSP3,GNB2,GNB4,GNG2,H3-3A/H3-3B,KDELR3,MYL5,NFATC3,PDE9A,PLCB1,PLCD3,PRKAR1B,PRKCD,PTP4A1,PTPN4,PTPN6,PTPN7,PTPRS,PYGL,SIRPA,SMPDL3A"
CD28 Signaling in T Helper Cells,0.367,-0.377964473,0.0667,"CALM1 (includes others),HLA-B,MAPK10,MAPK12,NFATC3,PIK3C2A,PIK3CD,PTPN6"
Heparan Sulfate Biosynthesis (Late Stages),0.376,1.341640786,0.0704,"EXT1,PNPLA7,SULT1A3/SULT1A4,SULT1B1,UST"
Sumoylation Pathway,0.376,0,0.068,"CDH1,CEBPA,MAPK10,MAPK12,RANGAP1,RHOBTB1,SP100"
Inhibition of Matrix Metalloproteases,0.381,,0.0769,"ADAM12,MMP25,TIMP2"
tRNA Charging,0.381,,0.0769,"CARS2,TARS3,YARS2"
PDGF Signaling,0.387,1.632993162,0.0698,"JAK2,MYC,PIK3C2A,PIK3CD,RALB,SYNJ2"
Apelin Cardiac Fibroblast Signaling Pathway,0.394,,0.087,"PRKAA1,SERPINE1"
"Superpathway of D-myo-inositol (1,4,5)-trisphosphate Metabolism",0.394,,0.087,"IMPA1,SYNJ2"
Inositol Pyrophosphates Biosynthesis,0.409,,0.125,PPIP5K1
Sphingosine and Sphingosine-1-phosphate Metabolism,0.409,,0.125,ASAH2B
HER-2 Signaling in Breast Cancer,0.41,,0.0714,"ITGB1,PARD6B,PIK3C2A,PIK3CD,PRKCD,RALB"
TR/RXR Activation,0.41,,0.0714,"HP,ME1,PIK3C2A,PIK3CD,SLC16A3,SREBF1"
VEGF Family Ligand-Receptor Interactions,0.41,1.632993162,0.0714,"PIK3C2A,PIK3CD,PLA2G4B,PRKCD,RALB,VEGFA"
Remodeling of Epithelial Adherens Junctions,0.414,,0.0735,"ACTN1,CDH1,MAPRE2,TUBA1A,TUBA1C"
Cell Cycle Regulation by BTG Family Proteins,0.417,,0.0811,"BTG2,CNOT7,PPP2R3A"
Polyamine Regulation in Colon Cancer,0.417,,0.0909,"MYC,SAT1"
Nitric Oxide Signaling in the Cardiovascular System,0.419,0.377964473,0.0707,"CALM1 (includes others),PIK3C2A,PIK3CD,PRKAA1,PRKAR1B,PRKCD,VEGFA"
p53 Signaling,0.43,-0.447213595,0.0714,"BIRC5,CDKN2A,GADD45B,MAPK14,PIK3C2A,PIK3CD,TP53I3"
ERK/MAPK Signaling,0.431,2.496150883,0.0674,"CREB5,DOCK1,H3-3A/H3-3B,ITGB1,MKNK1,MYC,PIK3C2A,PIK3CD,PLA2G4B,PPP2R3A,PRKAR1B,PRKCD,RALB"
Synaptic Long Term Potentiation,0.435,0.333333333,0.0698,"ADCY1,CALM1 (includes others),CREB5,GNA15,PLCB1,PLCD3,PRKAR1B,PRKCD,RALB"
Regulation of the Epithelial-Mesenchymal Transition Pathway,0.439,,0.0677,"CDH1,FRS2,FZD1,FZD2,ID2,JAG2,JAK2,NOTCH4,PARD6B,PIK3C2A,PIK3CD,RALB,WNT16"
Amyotrophic Lateral Sclerosis Signaling,0.442,-0.377964473,0.0722,"ALS2,CAPN7,CASP1,GRIK1,PIK3C2A,PIK3CD,VEGFA"
Putrescine Degradation III,0.443,,0.0952,"ALDH3B1,SAT1"
Phosphatidylcholine Biosynthesis I,0.455,,0.143,CEPT1
Superpathway of Serine and Glycine Biosynthesis I,0.455,,0.143,PHGDH
PXR/RXR Activation,0.457,,0.0769,"ABCB1,ABCB9,PCK2,PRKAR1B,SCD"
Role of BRCA1 in DNA Damage Response,0.462,,0.075,"FANCD2,HLTF,PHF10,RBL2,SMARCD3,UIMC1"
FXR/RXR Activation,0.467,,0.0714,"FBP1,IL1RN,ITIH4,MAPK10,MAPK12,ORM2,PCK2,RARA,SREBF1"
Regulation of eIF4 and p70S6K Signaling,0.47,0.816496581,0.0701,"EIF4EBP3,IRS1,ITGB1,MAPK11,MAPK12,MAPK14,MKNK1,PIK3C2A,PIK3CD,PPP2R3A,RALB"
Glioma Signaling,0.472,0.816496581,0.0727,"CALM1 (includes others),CDKN2A,IGF1R,PIK3C2A,PIK3CD,PRKCD,RALB,RBL2"
Cardiac ?-adrenergic Signaling,0.473,1.341640786,0.0709,"ADCY1,AKAP5,GNB2,GNB4,GNG2,PDE9A,PPP2R3A,PRKAR1B,SLC8A1,SMPDL3A"
Agrin Interactions at Neuromuscular Junction,0.475,1.341640786,0.0759,"AGRN,ITGB1,LAMC1,MAPK10,MAPK12,RALB"
BEX2 Signaling Pathway,0.475,1.632993162,0.0759,"BEX2,MAPK10,MAPK12,PLXNC1,PPP2R3A,VEGFA"
Thyroid Cancer Signaling,0.475,1.632993162,0.0759,"CDH1,IRS1,MYC,PIK3C2A,PIK3CD,RALB"
MIF-mediated Glucocorticoid Regulation,0.478,,0.0882,"CD14,PLA2G4B,TLR4"
Hereditary Breast Cancer Signaling,0.484,,0.0714,"CCNB1,FANCD2,GADD45B,HDAC4,HLTF,PHF10,PIK3C2A,PIK3CD,RALB,SMARCD3"
Chondroitin Sulfate Biosynthesis (Late Stages),0.491,0,0.0833,"CHPF,SULT1A3/SULT1A4,SULT1B1,UST"
Ovarian Cancer Signaling,0.494,1.632993162,0.0719,"CDKN2A,FZD1,FZD2,PIK3C2A,PIK3CD,PRKAR1B,PTGS1,RALB,VEGFA,WNT16"
GADD45 Signaling,0.5,,0.105,"CCNB1,GADD45B"
RhoA Signaling,0.5,2.121320344,0.0732,"ARHGAP9,ARHGEF11,BAIAP2,EPHA1,IGF1R,LIMK2,LPAR2,MYL5,SEPTIN4"
Adenine and Adenosine Salvage III,0.509,,0.167,HPRT1
Ceramide Degradation,0.509,,0.167,ASAH2B
Chondroitin and Dermatan Biosynthesis,0.509,,0.167,CHPF
Tryptophan Degradation to 2-amino-3-carboxymuconate Semialdehyde,0.509,,0.167,HAAO
nNOS Signaling in Neurons,0.509,,0.0851,"CALM1 (includes others),CAPN7,PFKM,PRKCD"
Neurotrophin/TRK Signaling,0.519,1.341640786,0.0789,"CREB5,FRS2,PIK3C2A,PIK3CD,RALB,SPRY2"
Fatty Acid ?-oxidation I,0.524,,0.0938,"ACSL1,EHHADH,SLC27A3"
Systemic Lupus Erythematosus Signaling,0.527,,0.0699,"FCGR2B,HLA-B,HLA-C,IL1RN,IL6R,LYN,NFATC3,PIK3C2A,PIK3CD,PRPF39,PTPN6,RALB,SNRNP25,SNRNP27,SNRNP48,TLR7"
Dermatan Sulfate Biosynthesis (Late Stages),0.529,1,0.087,"DSE,SULT1A3/SULT1A4,SULT1B1,UST"
Integrin Signaling,0.531,0.577350269,0.0704,"ACTN1,CAPN7,DOCK1,ITGA11,ITGB1,MAP3K11,MYL5,PARVB,PIK3C2A,PIK3CD,RALB,RHOBTB1,TNK2,TSPAN2,TSPAN3"
Methylglyoxal Degradation III,0.533,,0.111,"AKR1A1,ZADH2"
Purine Nucleotides Degradation II (Aerobic),0.533,,0.111,"ACPP,IMPDH1"
Valine Degradation I,0.533,,0.111,"ACADSB,EHHADH"
OX40 Signaling Pathway,0.533,,0.0778,"HLA-B,HLA-C,HLA-DPB1,HLA-DQA2,MAPK10,MAPK12,TNFRSF4"
Endometrial Cancer Signaling,0.539,1.341640786,0.0833,"CDH1,MYC,PIK3C2A,PIK3CD,RALB"
Cholecystokinin/Gastrin-mediated Signaling,0.548,2.121320344,0.0756,"IL1RN,MAPK10,MAPK12,MAPK14,MEF2A,PLCB1,PRKCD,RALB,RHOBTB1"
Hypoxia Signaling in the Cardiovascular System,0.55,,0.0811,"CREB5,UBE2E3,UBE2J1,UBE2K,UBE2N,VEGFA"
Dermatan Sulfate Biosynthesis,0.557,0.447213595,0.0847,"CHPF,DSE,SULT1A3/SULT1A4,SULT1B1,UST"
Chronic Myeloid Leukemia Signaling,0.561,,0.0777,"CDKN2A,GAB2,HDAC4,MYC,PIK3C2A,PIK3CD,RALB,RBL2"
Caveolar-mediated Endocytosis Signaling,0.567,,0.0822,"CD55,FLOT2,HLA-B,HLA-C,ITGA11,ITGB1"
GPCR-Mediated Integration of Enteroendocrine Signaling Exemplified by an L Cell,0.567,0.816496581,0.0822,"ADCY1,GNA15,PLCB1,PLCD3,PRKAR1B,VIPR1"
"D-myo-inositol (1,4,5)-trisphosphate Degradation",0.568,,0.118,"IMPA1,SYNJ2"
Mitochondrial L-carnitine Shuttle Pathway,0.568,,0.118,"ACSL1,SLC27A3"
?-linolenate Biosynthesis II (Animals),0.568,,0.118,"ACSL1,SLC27A3"
Role of RIG1-like Receptors in Antiviral Innate Immunity,0.571,0,0.0909,"DHX58,IRF7,TRAF6,TRIM25"
Agranulocyte Adhesion and Diapedesis,0.574,,0.0725,"CCL3,CCL4,CCL5,CXCR1,IL1RN,ITGB1,JAM3,MMP25,MYH7B,MYL5,PPBP,SDC4,SELL,XCL2"
Neuroprotective Role of THOP1 in Alzheimer's Disease,0.574,0.816496581,0.0769,"APP,CTSG,ECE1,ENDOU,HLA-B,HLA-C,PRKAR1B,PRSS1,ST14"
Dopamine Degradation,0.575,,0.1,"ALDH3B1,SULT1A3/SULT1A4,SULT1B1"
Lysine Degradation II,0.576,,0.2,AASS
Lysine Degradation V,0.576,,0.2,PIPOX
Serine Biosynthesis,0.576,,0.2,PHGDH
dTMP De Novo Biosynthesis,0.576,,0.2,TYMS
BAG2 Signaling Pathway,0.593,1,0.093,"HSPA1A/HSPA1B,HSPA6,MAPK14,MYC"
Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza,0.593,,0.093,"CCL3,CCL4,CCL5,IL1RN"
Role of p14/p19ARF in Tumor Suppression,0.602,,0.103,"CDKN2A,PIK3C2A,PIK3CD"
Sonic Hedgehog Signaling,0.602,,0.103,"ARRB2,CCNB1,PRKAR1B"
Androgen Biosynthesis,0.606,,0.125,"HSD3B7,SRD5A3"
Glutaryl-CoA Degradation,0.606,,0.125,"EHHADH,GCDH"
Estrogen Receptor Signaling,0.612,1.459600898,0.0701,"ADCY1,CREB5,GNA15,GNAO1,GNG2,GPER1,IGF1R,JAK2,LIMK2,MMP25,MT-ATP6,MYC,MYL5,PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKAA1,PRKAR1B,PRKCD,RALB,SHC3,VEGFA"
NGF Signaling,0.615,1.666666667,0.0789,"CREB5,MAP3K11,MAPK10,MAPK12,PIK3C2A,PIK3CD,PRKCD,RALB,TRAF6"
Synaptic Long Term Depression,0.616,1.941450687,0.0741,"CACNA1F,CACNA2D4,CACNG6,GNA15,GNAO1,IGF1R,LYN,PLA2G4B,PLAAT5,PLCB1,PLCD3,PPP2R3A,PRKCD,RALB"
Intrinsic Prothrombin Activation Pathway,0.616,2,0.0952,"COL18A1,F12,F13A1,F5"
Role of IL-17F in Allergic Inflammatory Airway Diseases,0.616,,0.0952,"CCL4,CREB5,IL17RA,TRAF6"
EGF Signaling,0.635,1,0.0909,"MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD"
SPINK1 General Cancer Pathway,0.637,0.816496581,0.087,"IL6R,JAK2,PIK3C2A,PIK3CD,PRSS1,RALB"
14-3-3-mediated Signaling,0.639,0.707106781,0.0787,"MAPK10,MAPK12,PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKCD,RALB,TUBA1A,TUBA1C"
Isoleucine Degradation I,0.647,,0.133,"ACADSB,EHHADH"
Bladder Cancer Signaling,0.649,,0.0825,"CDH1,CDKN2A,DAPK1,MMP25,MYC,RALB,RASSF1,VEGFA"
Salvage Pathways of Pyrimidine Ribonucleotides,0.649,0.707106781,0.0825,"APOBEC3A,CDADC1,CMPK2,DAPK1,LIMK2,NME7,PRKAA1,PRKCD"
Transcriptional Regulatory Network in Embryonic Stem Cells,0.657,,0.0926,"GATA6,H3-3A/H3-3B,RIF1,SMARCAD1,TRIM24"
PEDF Signaling,0.659,0.816496581,0.0854,"ARHGAP22,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,RALB"
Arsenate Detoxification I (Glutaredoxin),0.66,,0.25,GLRX2
"Fatty Acid ?-oxidation III (Unsaturated, Odd Number)",0.66,,0.25,EHHADH
Heme Degradation,0.66,,0.25,HMOX1
N-acetylglucosamine Degradation II,0.66,,0.25,GNPDA2
Pentose Phosphate Pathway (Oxidative Branch),0.66,,0.25,PGD
Spermine and Spermidine Degradation I,0.66,,0.25,SAT1
Lymphotoxin ? Receptor Signaling,0.679,0,0.0943,"LTBR,PIK3C2A,PIK3CD,RELB,TRAF6"
Antigen Presentation Pathway,0.692,,0.103,"HLA-B,HLA-C,HLA-DPB1,HLA-DQA2"
ErbB Signaling,0.698,1.889822365,0.0851,"MAPK10,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,PRKCD,RALB"
Androgen Signaling,0.718,1.632993162,0.0809,"CACNA1F,CACNA2D4,CACNG6,CALM1 (includes others),GNA15,GNAO1,GNB2,GNB4,GNG2,PRKAR1B,PRKCD"
Ephrin Receptor Signaling,0.719,1.264911064,0.0778,"CREB5,EPHA1,EPHA2,EPHB2,GNA15,GNAO1,GNB2,GNB4,GNG2,ITGB1,JAK2,LIMK2,RALB,VEGFA"
Virus Entry via Endocytic Pathways,0.719,,0.0841,"AP1B1,CD55,HLA-B,HLA-C,ITGB1,PIK3C2A,PIK3CD,PRKCD,RALB"
Docosahexaenoic Acid (DHA) Signaling,0.72,,0.105,"APP,BCL2A1,PIK3C2A,PIK3CD"
Glioblastoma Multiforme Signaling,0.722,1.154700538,0.0788,"CDKN2A,FZD1,FZD2,IGF1R,MYC,PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKCD,RALB,RHOBTB1,WNT16"
HMGB1 Signaling,0.722,1.889822365,0.0788,"IFNGR2,MAPK10,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,RALB,RHOBTB1,SERPINE1,TLR4,TNFSF10,TNFSF13"
LXR/RXR Activation,0.725,-1.414213562,0.0826,"ABCA1,ABCG1,CD14,IL1RN,ITIH4,ORM2,S100A8,SCD,SREBF1,TLR4"
Relaxin Signaling,0.726,0,0.08,"ADCY1,GNA15,GNAO1,GNB2,GNB4,GNG2,PDE9A,PIK3C2A,PIK3CD,PRKAR1B,SMPDL3A,VEGFA"
VDR/RXR Activation,0.733,-0.447213595,0.0897,"CALB1,CCL5,CD14,CEBPA,IGFBP3,PRKCD,SERPINB1"
"PD-1, PD-L1 cancer immunotherapy pathway",0.736,0.377964473,0.0849,"HLA-B,HLA-C,HLA-DPB1,HLA-DQA2,IFNGR2,JAK2,PDCD1,PIK3C2A,PIK3CD"
Fatty Acid Activation,0.743,,0.154,"ACSL1,SLC27A3"
Leukotriene Biosynthesis,0.743,,0.154,"ALOX5,DPEP3"
Urate Biosynthesis/Inosine 5'-phosphate Degradation,0.743,,0.154,"ACPP,IMPDH1"
Notch Signaling,0.749,,0.108,"HEY2,JAG2,MAML3,NOTCH4"
Melanoma Signaling,0.75,,0.1,"CDH1,CDKN2A,PIK3C2A,PIK3CD,RALB"
Synaptogenesis Signaling Pathway,0.752,1.876629727,0.0737,"ADCY1,AP1B1,CALM1 (includes others),CDH1,CDH23,CDH26,CHN1,CREB5,EIF4EBP3,EPHA1,EPHA2,EPHB2,LYN,MAPK14,PIK3C2A,PIK3CD,PRKAR1B,PRKCD,RALB,SHC3,STX1A,TIAM1,YES1"
Antiproliferative Role of Somatostatin Receptor 2,0.752,0.447213595,0.0909,"GNB2,GNB4,GNG2,PIK3C2A,PIK3CD,PTPN6,RALB"
GP6 Signaling Pathway,0.756,1.264911064,0.084,"CALM1 (includes others),COL18A1,COL6A6,COL9A2,LAMB3,LAMC1,LYN,PIK3C2A,PIK3CD,PRKCD"
Phospholipases,0.759,0.447213595,0.0952,"HMOX1,PLA2G4B,PLAAT5,PLCB1,PLCD3,PLD3"
"1,25-dihydroxyvitamin D3 Biosynthesis",0.772,,0.333,POR
Coenzyme A Biosynthesis,0.772,,0.333,COASY
D-glucuronate Degradation I,0.772,,0.333,AKR1A1
N-acetylglucosamine Degradation I,0.772,,0.333,GNPDA2
Oxidized GTP and dGTP Detoxification,0.772,,0.333,NUDT1
Thiosulfate Disproportionation III (Rhodanese),0.772,,0.333,TST
Erythropoietin Signaling,0.772,,0.0921,"JAK2,PIK3C2A,PIK3CD,PRKCD,PTPN6,RALB,SOCS3"
PPAR?/RXR? Activation,0.778,-0.904534034,0.0789,"ABCA1,ACVR1,ACVR1B,ADCY1,GNA15,HELZ2,IRS1,JAK2,MAPK14,PLCB1,PLCD3,PRKAA1,PRKAR1B,RALB,TRAF6"
Wnt/Ca+ pathway,0.782,0,0.0968,"CREB5,FZD1,FZD2,NFATC3,PLCB1,PLCD3"
PI3K/AKT Signaling,0.782,0.816496581,0.08,"CSF2RB,CXCR1,GAB2,GDF15,IL13RA1,IL17RA,IL4R,IL6R,ITGB1,JAK2,PIK3CD,PPP2R3A,RALB,SYNJ2"
CTLA4 Signaling in Cytotoxic T Lymphocytes,0.788,,0.0899,"AP1B1,HLA-B,HLA-C,JAK2,PIK3C2A,PIK3CD,PPP2R3A,PTPN6"
Crosstalk between Dendritic Cells and Natural Killer Cells,0.788,2.236067977,0.0899,"CSF2RB,HLA-B,HLA-C,KIR3DL2,LTBR,TLR4,TLR7,TNFSF10"
Actin Cytoskeleton Signaling,0.796,2.672612419,0.078,"ABI2,ACTN1,ARHGAP24,BAIAP2,CD14,CYFIP1,DOCK1,FGD3,ITGB1,LIMK2,MYH7B,MYL5,PIK3C2A,PIK3CD,RALB,TIAM1,VAV2"
Hematopoiesis from Multipotent Stem Cells,0.799,,0.167,"CSF1,IL7"
SAPK/JNK Signaling,0.804,1.666666667,0.0882,"GNG2,IRS1,MAP3K11,MAPK10,MAPK12,NFATC3,PIK3C2A,PIK3CD,RALB"
Differential Regulation of Cytokine Production in Intestinal Epithelial Cells by IL-17A and IL-17F,0.807,,0.13,"CCL3,CCL4,CCL5"
Ethanol Degradation IV,0.807,,0.13,"ACSL1,ACSS2,ALDH3B1"
Tryptophan Degradation III (Eukaryotic),0.807,,0.13,"EHHADH,GCDH,HAAO"
Wnt/?-catenin Signaling,0.809,0.301511345,0.0809,"ACVR1,ACVR1B,CDH1,CDKN2A,FZD1,FZD2,GNAO1,LRP6,MYC,PPP2R3A,RARA,SFRP2,TLE3,WNT16"
Coagulation System,0.81,1,0.114,"F12,F13A1,F5,SERPINE1"
Sirtuin Signaling Pathway,0.811,0.229415734,0.0756,"ABCA1,ACSS2,APP,CDH1,EPAS1,GADD45B,H3-3A/H3-3B,MAPK12,MT-ATP6,MT-ND3,MT-ND4,MYC,PCK2,PFKFB3,PFKM,PRKAA1,RRP9,SCNN1A,SREBF1,TIMM9,TUBA1A,TUBA1C"
Aldosterone Signaling in Epithelial Cells,0.817,0,0.0823,"DNAJB14,DNAJC19,DNAJC27,HSPA1A/HSPA1B,HSPA6,PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKCD,SACS,SASS6,SCNN1A"
p70S6K Signaling,0.823,1.507556723,0.0853,"F2RL3,IL4R,IRS1,LYN,PIK3C2A,PIK3CD,PLCB1,PLCD3,PPP2R3A,PRKCD,RALB"
Ephrin A Signaling,0.829,,0.106,"EPHA1,EPHA2,PIK3C2A,PIK3CD,VAV2"
Stearate Biosynthesis I (Animals),0.829,1.341640786,0.106,"ACSL1,SLC27A3,SRD5A3,TBXAS1,ZADH2"
Germ Cell-Sertoli Cell Junction Signaling,0.837,,0.0819,"ACTN1,CDH1,ITGB1,LIMK2,MAP3K11,MAPK10,MAPK12,MAPK14,PIK3C2A,PIK3CD,RALB,RHOBTB1,TUBA1A,TUBA1C"
Sertoli Cell-Sertoli Cell Junction Signaling,0.843,,0.0811,"ACTN1,CDH1,ITGB1,JAM3,MAP3K11,MAPK10,MAPK11,MAPK12,MAPK14,OCLN,PRKAR1B,RALB,TJAP1,TUBA1A,TUBA1C"
Protein Ubiquitination Pathway,0.844,,0.0769,"DNAJB14,DNAJC19,DNAJC27,HLA-B,HLA-C,HSPA1A/HSPA1B,HSPA6,SACS,SASS6,SMURF2,TRAF6,UBE2E3,UBE2J1,UBE2K,UBE2N,UBR1,UCHL5,USP33,USP35,USP37,USP48"
Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I,0.849,,0.136,"CMPK2,NME7,TYMS"
HIF1? Signaling,0.857,,0.0885,"MAPK10,MAPK11,MAPK12,MAPK14,MMP25,PIK3C2A,PIK3CD,RALB,SLC2A3,VEGFA"
Ephrin B Signaling,0.858,1,0.0972,"EPHB2,GNA15,GNAO1,GNB2,GNB4,GNG2,VAV2"
FGF Signaling,0.888,0.377964473,0.0952,"CREB5,FRS2,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,PTPN6"
HGF Signaling,0.893,1.897366596,0.0901,"CDKN2A,DOCK1,ITGB1,MAP3K11,MAPK10,MAPK12,PIK3C2A,PIK3CD,PRKCD,RALB"
ATM Signaling,0.899,1.133893419,0.0928,"CCNB1,CREB5,FANCD2,GADD45B,MAPK10,MAPK11,MAPK12,MAPK14,PPP2R3A"
PAK Signaling,0.899,1.414213562,0.0928,"ARHGAP10,ITGB1,LIMK2,MAPK10,MAPK12,MYL5,PIK3C2A,PIK3CD,RALB"
LPS/IL-1 Mediated Inhibition of RXR Function,0.902,0.333333333,0.0804,"ABCA1,ABCB1,ABCB9,ABCG1,ACSL1,ALDH3B1,CD14,FABP5,IL1RN,MYD88,RARA,SLC27A3,SREBF1,SULT1A3/SULT1A4,SULT1B1,TLR4,TRAF6,UST"
Granulocyte Adhesion and Diapedesis,0.913,,0.0833,"CCL3,CCL4,CCL5,CSF3R,FPR2,HRH2,IL1RN,ITGB1,JAM3,MMP25,PPBP,SDC3,SDC4,SELL,XCL2"
RhoGDI Signaling,0.913,-1.666666667,0.0833,"ARHGAP9,ARHGEF11,ARHGEF5,CDH1,CDH23,CDH26,GNA15,GNAO1,GNB2,GNB4,GNG2,ITGB1,LIMK2,MYL5,RHOBTB1"
4-1BB Signaling in T Lymphocytes,0.914,,0.125,"MAPK10,MAPK11,MAPK12,MAPK14"
Ethanol Degradation II,0.914,2,0.125,"ACSL1,ACSS2,AKR1A1,ALDH3B1"
Iron homeostasis signaling pathway,0.923,,0.0876,"BMP6,BMPR1A,CD163,EPAS1,GDF15,HMOX1,HP,IL6R,JAK2,LYRM4,SLC11A1,SMAD1"
Pancreatic Adenocarcinoma Signaling,0.93,1.897366596,0.0917,"BIRC5,CDKN2A,HMOX1,JAK2,MAPK10,MAPK12,PIK3C2A,PIK3CD,PLD3,VEGFA"
Dolichyl-diphosphooligosaccharide Biosynthesis,0.932,,0.2,"ALG3,ALG6"
Prostanoid Biosynthesis,0.932,,0.2,"PTGS1,TBXAS1"
Unfolded protein response,0.933,2.236067977,0.107,"CEBPA,DDIT3,HSPA1A/HSPA1B,HSPA6,OS9,SREBF1"
Alanine Biosynthesis II,0.935,,0.5,GPT2
Alanine Degradation III,0.935,,0.5,GPT2
Cardiolipin Biosynthesis II,0.935,,0.5,PGS1
Guanine and Guanosine Salvage I,0.935,,0.5,HPRT1
Spliceosomal Cycle,0.935,,0.5,U2AF1/U2AF1L5
Taurine Biosynthesis,0.935,,0.5,CSAD
CDP-diacylglycerol Biosynthesis I,0.942,,0.15,"AGPAT2,AGPAT3,GPAM"
CDK5 Signaling,0.95,-0.707106781,0.0926,"ADCY1,ITGB1,LAMC1,MAPK10,MAPK11,MAPK12,MAPK14,PPP2R3A,PRKAR1B,RALB"
Fc? Receptor-mediated Phagocytosis in Macrophages and Monocytes,0.961,2.333333333,0.0957,"DOCK1,GAB2,HMOX1,LYN,NCF1,PLD3,PRKCD,VAV2,YES1"
Melanocyte Development and Pigmentation Signaling,0.961,0.707106781,0.0957,"ADCY1,CREB5,PIK3C2A,PIK3CD,POMC,PRKAR1B,PTPN6,RALB,SH2B2"
Adipogenesis pathway,0.975,,0.0896,"AGPAT2,BMPR1A,CEBPA,DDIT3,FZD1,FZD2,HDAC4,KLF5,PAXIP1,PPIP5K1,SMAD1,SREBF1"
Role of MAPK Signaling in the Pathogenesis of Influenza,0.978,,0.1,"CCL5,MAPK10,MAPK11,MAPK12,MAPK14,PLA2G4B,PLAAT5,RALB"
MIF Regulation of Innate Immunity,0.982,2.236067977,0.119,"CD14,MAPK10,MAPK12,PLA2G4B,TLR4"
NRF2-mediated Oxidative Stress Response,0.99,1.264911064,0.0847,"AKR1A1,DNAJB14,DNAJC19,FKBP5,HACD3,HMOX1,JUNB,MAFG,MAPK14,PIK3C2A,PIK3CD,PMF1/PMF1-BGLAP,PRKCD,RALB,UBE2E3,UBE2K"
Senescence Pathway,0.992,0.426401433,0.08,"ACVR1,ACVR1B,CALM1 (includes others),CAPN7,CCNB1,CDKN2A,GADD45B,MAPK12,MAPK14,NFATC3,PDK4,PHF1,PIK3C2A,PIK3CD,PPP2R3A,RALB,RBL2,SERPINE1,SMAD1,SMAD7,TLR2,TRAF6"
Oxidative Ethanol Degradation III,0.994,,0.158,"ACSL1,ACSS2,ALDH3B1"
IL-3 Signaling,1,1.414213562,0.101,"CSF2RB,GAB2,JAK2,PIK3C2A,PIK3CD,PRKCD,PTPN6,RALB"
Phosphatidylethanolamine Biosynthesis II,1.01,,0.222,"CEPT1,ETNK1"
nNOS Signaling in Skeletal Muscle Cells,1.02,,0.122,"CACNA1F,CACNA2D4,CACNG6,CALM1 (includes others),SNTB2"
Netrin Signaling,1.03,1.133893419,0.108,"CACNA1F,CACNA2D4,CACNG6,ENAH,NFATC3,PRKAR1B,UNC5A"
G?q Signaling,1.04,-0.301511345,0.0886,"CALM1 (includes others),CHRM5,GNA15,GNB2,GNB4,GNG2,HMOX1,NFATC3,PIK3C2A,PIK3CD,PLCB1,PLD3,PRKCD,RHOBTB1"
Differential Regulation of Cytokine Production in Macrophages and T Helper Cells by IL-17A and IL-17F,1.05,,0.167,"CCL3,CCL4,CCL5"
Adrenomedullin signaling pathway,1.08,1,0.0863,"ADCY1,ADM,CALM1 (includes others),CFH,GNA15,IL1RN,MAPK10,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKAR1B,RALB,SHC3"
Leukocyte Extravasation Signaling,1.08,1.603567451,0.0863,"ACTN1,ARHGAP9,CYBB,ITGB1,JAM3,MAPK10,MAPK11,MAPK12,MAPK14,MMP25,NCF1,NCF4,PIK3C2A,PIK3CD,PRKCD,TIMP2,VAV2"
UVC-Induced MAPK Signaling,1.08,2.236067977,0.118,"MAPK10,MAPK11,MAPK12,MAPK14,PRKCD,RALB"
Thrombopoietin Signaling,1.09,1.889822365,0.111,"GAB2,JAK2,MYC,PIK3C2A,PIK3CD,PRKCD,RALB"
RANK Signaling in Osteoclasts,1.1,0.707106781,0.102,"CALM1 (includes others),MAP3K11,MAPK10,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,TRAF6"
IL-15 Signaling,1.1,2.121320344,0.107,"JAK2,MAPK11,MAPK12,MAPK14,MYC,PIK3C2A,PIK3CD,RALB"
Huntington's Disease Signaling,1.12,-1.603567451,0.0844,"ARFIP2,CAPN7,CASP1,CASP4,CASP5,CREB5,GNA15,GNB2,GNB4,GNG2,HDAC4,HSPA1A/HSPA1B,HSPA6,IGF1R,PACSIN1,PIK3C2A,PIK3CD,PLCB1,PRKCD,STX1A"
Role of NFAT in Regulation of the Immune Response,1.12,0.832050294,0.0884,"AKAP5,CALM1 (includes others),FCGR2B,GNA15,GNAO1,GNB2,GNB4,GNG2,HLA-B,LYN,MEF2A,NFATC3,PIK3C2A,PIK3CD,PLCB1,RALB"
Amyloid Processing,1.12,1,0.12,"APP,CAPN7,MAPK11,MAPK12,MAPK14,PRKAR1B"
Epithelial Adherens Junction Signaling,1.14,,0.0921,"ACTN1,ACVR1,ACVR1B,BAIAP2,CDH1,MYH7B,MYL5,NOTCH4,RALB,SSX2IP,TUBA1A,TUBA1C,VAV2,YES1"
T Helper Cell Differentiation,1.16,,0.11,"BCL6,HLA-B,ICOSLG/LOC102723996,IFNGR2,IL23R,IL4R,IL6R,RORC"
UVA-Induced MAPK Signaling,1.17,-0.447213595,0.102,"MAPK10,MAPK11,MAPK12,MAPK14,PARP9,PIK3C2A,PIK3CD,PLCB1,PLCD3,RALB"
Opioid Signaling Pathway,1.17,2.064741605,0.085,"ADCY1,AP1B1,ARRB2,CACNA1F,CACNA2D4,CACNG6,CALM1 (includes others),CREB5,GNAO1,GNG2,LYN,MAPK12,MYC,OPRL1,PLCB1,POMC,PRKAR1B,PRKCD,RALB,RGS12,YES1"
Extrinsic Prothrombin Activation Pathway,1.18,,0.188,"F12,F13A1,F5"
Parkinson's Signaling,1.18,,0.188,"MAPK11,MAPK12,MAPK14"
Apelin Liver Signaling Pathway,1.18,2,0.154,"COL18A1,IRS1,MAPK10,MAPK12"
PCP pathway,1.18,1.632993162,0.117,"FZD1,FZD2,JUNB,MAPK10,MAPK12,VANGL1,WNT16"
G Beta Gamma Signaling,1.21,1.897366596,0.0984,"ADCY1,CACNA1F,CACNA2D4,CACNG6,GNA15,GNAO1,GNB2,GNB4,GNG2,PRKAR1B,PRKCD,RALB"
Human Embryonic Stem Cell Pluripotency,1.21,,0.0963,"ACVR1,BMP6,BMPR1A,FZD1,FZD2,NODAL,PIK3C2A,PIK3CD,S1PR1,S1PR3,SMAD1,SMAD7,WNT16"
?-Adrenergic Signaling,1.21,1.341640786,0.104,"ADCY1,CALM1 (includes others),GNB2,GNB4,GNG2,PRKAR1B,PRKCD,PYGL,RALB,SLC8A1"
Methylthiopropionate Biosynthesis,1.22,,1,ADI1
GM-CSF Signaling,1.24,1.889822365,0.114,"BCL2A1,CSF2RA,CSF2RB,JAK2,LYN,PIK3C2A,PIK3CD,RALB"
Choline Biosynthesis III,1.25,,0.2,"CEPT1,HMOX1,PLD3"
Apelin Adipocyte Signaling Pathway,1.25,0.377964473,0.11,"ADCY1,CYBB,MAPK10,MAPK11,MAPK12,MAPK14,NCF1,PRKAA1,PRKAR1B"
Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency,1.28,1,0.101,"BMP6,BMPR1A,FZD1,FZD2,GATA6,JAK2,PIK3C2A,PIK3CD,RALB,RIF1,SMAD1,WNT16"
"Role of JAK1, JAK2 and TYK2 in Interferon Signaling",1.28,,0.167,"IFNGR2,JAK2,PTPN6,STAT2"
Inhibition of Angiogenesis by TSP1,1.3,2,0.147,"MAPK10,MAPK11,MAPK12,MAPK14,VEGFA"
Chemokine Signaling,1.31,0,0.113,"CALM1 (includes others),CCL4,CCL5,LIMK2,MAPK11,MAPK12,MAPK14,PLCB1,RALB"
FLT3 Signaling in Hematopoietic Progenitor Cells,1.31,2.121320344,0.113,"CREB5,GAB2,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,RALB,STAT2"
JAK/Stat Signaling,1.31,1,0.113,"JAK2,PIK3C2A,PIK3CD,PTPN6,RALB,SOCS2,SOCS3,SOCS5,STAT2"
Glucocorticoid Receptor Signaling,1.31,,0.0833,"CCL3,CCL5,CD163,CEBPA,FKBP5,HLTF,HSPA1A/HSPA1B,HSPA6,IL1RN,JAK2,KRT10,KRT18,MAPK10,MAPK11,MAPK12,MAPK14,NFATC3,PCK2,PHF10,PIK3C2A,PIK3CD,POMC,PRKAA1,RALB,SERPINE1,SMARCD3,TRAF6,VIPR1"
G?12/13 Signaling,1.32,1.941450687,0.1,"CDH1,CDH23,CDH26,F2RL3,LPAR2,MAPK10,MAPK12,MEF2A,MYL5,PIK3C2A,PIK3CD,RALB,VAV2"
Fc Epsilon RI Signaling,1.32,2.110579412,0.103,"LYN,MAPK10,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,PLA2G4B,PRKCD,RALB,SYNJ2,VAV2"
Sphingosine-1-phosphate Signaling,1.32,-1.264911064,0.103,"ADCY1,ASAH2B,CASP1,CASP4,CASP5,PIK3C2A,PIK3CD,PLCB1,PLCD3,RHOBTB1,S1PR1,S1PR3"
IGF-1 Signaling,1.33,1.897366596,0.106,"IGF1R,IGFBP3,IRS1,JAK2,PIK3C2A,PIK3CD,PRKAR1B,RALB,SOCS2,SOCS3,SOCS5"
Reelin Signaling in Neurons,1.34,1.941450687,0.101,"APP,ARHGEF11,ARHGEF5,CNR1,ITGB1,LYN,MAP3K11,MAPK10,MAPK12,PDK4,PIK3C2A,PIK3CD,YES1"
White Adipose Tissue Browning Pathway,1.34,2.309401077,0.101,"ADCY1,CACNA1F,CACNA2D4,CACNG6,CREB5,GPBAR1,MAPK11,MAPK12,MAPK14,PRKAA1,PRKAR1B,RARA,VEGFA"
IL-9 Signaling,1.35,0,0.152,"IRS1,PIK3C2A,PIK3CD,SOCS2,SOCS3"
Gustation Pathway,1.37,,0.0974,"ADCY1,CACNA1F,CACNA2D4,CACNG6,GNG2,P2RX1,P2RX4,P2RX5,PDE9A,PRKAR1B,SCNN1A,SMPDL3A,TAS1R3,TAS2R20,TAS2R43"
IL-7 Signaling Pathway,1.37,1.133893419,0.115,"BCL6,IL7,LYN,MAPK11,MAPK12,MAPK14,MYC,PIK3C2A,PIK3CD"
Cdc42 Signaling,1.37,2.713602101,0.0958,"BAIAP2,FGD3,HLA-B,HLA-C,HLA-DPB1,HLA-DQA2,ITGB1,LIMK2,MAP3K11,MAPK10,MAPK11,MAPK12,MAPK14,MYL5,TNK2,VAV2"
CREB Signaling in Neurons,1.37,-0.301511345,0.0918,"ADCY1,CACNA1F,CACNA2D4,CACNG6,CALM1 (includes others),CREB5,GNA15,GNAO1,GNB2,GNB4,GNG2,GRIK1,PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKAR1B,PRKCD,RALB"
P2Y Purigenic Receptor Signaling Pathway,1.39,0.301511345,0.102,"ADCY1,CREB5,GNB2,GNB4,GNG2,MYC,PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKAR1B,PRKCD,RALB"
Calcium Signaling,1.39,2.138089935,0.0922,"AKAP5,CACNA1F,CACNA2D4,CACNG6,CALM1 (includes others),CHRNA2,CHRNB2,CHRNE,CREB5,GRIK1,HDAC4,MEF2A,MYH7B,MYL5,NFATC3,PRKAR1B,SLC8A1,SLC8B1,TRPC1"
CD40 Signaling,1.4,0.816496581,0.123,"MAPK10,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,PTGS1,TRAF6"
Phosphatidylglycerol Biosynthesis II (Non-plastidic),1.4,1,0.182,"AGPAT2,AGPAT3,GPAM,PGS1"
NAD Phosphorylation and Dephosphorylation,1.41,,0.231,"ACPP,NADK,PXYLP1"
Role of IL-17A in Psoriasis,1.41,,0.231,"IL17RA,S100A8,S100A9"
GDNF Family Ligand-Receptor Interactions,1.43,1.889822365,0.118,"DOK3,FRS2,IRS1,MAPK10,MAPK12,PDLIM7,PIK3C2A,PIK3CD,RALB"
Macropinocytosis Signaling,1.43,1.889822365,0.118,"ANKFY1,CD14,CSF1,CSF1R,ITGB1,PIK3C2A,PIK3CD,PRKCD,RALB"
PI3K Signaling in B Lymphocytes,1.43,0.832050294,0.101,"CALM1 (includes others),DAPP1,FCGR2B,IL4R,IRS1,LYN,NFATC3,PIK3AP1,PIK3CD,PLCB1,PLCD3,RALB,TLR4,VAV2"
Phospholipase C Signaling,1.45,1.697749375,0.0895,"ADCY1,ARHGEF11,ARHGEF5,CALM1 (includes others),CREB5,FCGR2B,GNB2,GNB4,GNG2,HDAC4,HMOX1,ITGB1,LYN,MEF2A,MYL5,NFATC3,PLA2G4B,PLCB1,PLCD3,PLD3,PRKCD,RALB,RHOBTB1"
G Protein Signaling Mediated by Tubby,1.45,,0.161,"GNB2,GNB4,GNG2,JAK2,PLCB1"
Apelin Cardiomyocyte Signaling Pathway,1.46,1,0.111,"MAPK10,MAPK11,MAPK12,MAPK14,MYL5,PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKCD,SLC8A1"
Activation of IRF by Cytosolic Pattern Recognition Receptors,1.47,1.414213562,0.127,"DHX58,IFIT2,IRF7,IRF9,MAPK10,MAPK12,STAT2,TRAF6"
Leptin Signaling in Obesity,1.49,0.447213595,0.122,"ADCY1,JAK2,PIK3C2A,PIK3CD,PLCB1,PLCD3,POMC,PRKAR1B,SOCS3"
Myo-inositol Biosynthesis,1.5,,0.4,"IMPA1,ISYNA1"
Glycogen Degradation II,1.5,,0.25,"PGM5,PYGL,TYMP"
Inhibition of ARE-Mediated mRNA Degradation Pathway,1.51,3.050851079,0.107,"CNOT11,CNOT4,CNOT7,MAPK11,MAPK12,MAPK14,PAPOLG,POMC,PPP2R3A,PRKAR1B,TIA1,TNFSF10,TNFSF13"
GNRH Signaling,1.52,1.732050808,0.0983,"ADCY1,CACNA1F,CACNA2D4,CACNG6,CALM1 (includes others),CREB5,GNA15,GNG2,MAP3K11,MAPK10,MAPK11,MAPK12,MAPK14,PLCB1,PRKAR1B,PRKCD,RALB"
BMP signaling pathway,1.52,1.666666667,0.118,"BMP6,BMPR1A,MAPK10,MAPK11,MAPK12,MAPK14,PRKAR1B,RALB,SMAD1,SMAD7"
Molecular Mechanisms of Cancer,1.53,,0.0844,"ADCY1,ARHGEF11,ARHGEF5,BMP6,BMPR1A,CDH1,CDK14,CDKN2A,FANCD2,FZD1,FZD2,GAB2,GNA15,GNAO1,IRS1,ITGB1,JAK2,LRP6,MAPK10,MAPK11,MAPK12,MAPK14,MYC,PIK3C2A,PIK3CD,PLCB1,PRKAR1B,PRKCD,RALB,RHOBTB1,SMAD1,SMAD7,WNT16"
Th1 Pathway,1.54,1.897366596,0.107,"HLA-B,HLA-DPB1,HLA-DQA2,ICOSLG/LOC102723996,IFNGR2,IL27,IL6R,JAK2,NFATC3,NOTCH4,PIK3C2A,PIK3CD,SOCS3"
eNOS Signaling,1.54,0.534522484,0.101,"ADCY1,AQP3,CALM1 (includes others),CHRM5,CHRNA2,CHRNB2,CHRNE,HSPA1A/HSPA1B,HSPA6,LPAR2,PIK3C2A,PIK3CD,PRKAA1,PRKAR1B,PRKCD,VEGFA"
Hepatic Cholestasis,1.54,,0.0973,"ABCB1,ADCY1,CD14,HSD3B7,IL1RN,IRAK3,IRAK4,MAPK10,MAPK12,MYD88,PRKAR1B,PRKCD,RARA,SREBF1,TLR4,TNFSF10,TNFSF13,TRAF6"
Breast Cancer Regulation by Stathmin1,1.54,,0.0795,"ADGRB2,ADGRE2,ADORA2B,ARHGEF11,ARHGEF5,BMP6,C3AR1,CHRM5,CNR1,CREB5,CXCR1,F2RL3,FFAR2,FPR2,FZD1,FZD2,GNB2,GNB4,GNG2,GPER1,GPR155,GPR174,GPR89A/GPR89B,HCAR2,HCAR3,HRH2,LPAR2,NTSR1,OPRL1,PIK3C2A,PIK3CD,PLCB1,PPP2R3A,PRKAR1B,PRKCD,PTGDR,PTGER4,RALB,S1PR1,S1PR3,SLC52A1,SSTR3,TAS1R3,TUBA1A,TUBA1C,VEGFA,VIPR1"
Paxillin Signaling,1.55,1.897366596,0.111,"ACTN1,ARFIP2,DOCK1,ITGA11,ITGB1,MAPK10,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,RALB"
Melatonin Signaling,1.56,-1,0.125,"CALM1 (includes others),GNAO1,PLCB1,PLCD3,PRKAR1B,PRKCD,RORA,RORB,RORC"
Cardiac Hypertrophy Signaling (Enhanced),1.57,2.794782784,0.0821,"ACVR1,ACVR1B,ADCY1,CALM1 (includes others),CSF2RB,CXCR1,CYBB,FZD1,FZD2,GNA15,GNG2,HDAC4,IGF1R,IL13RA1,IL17RA,IL4R,IL6R,ITGB1,JAK2,MAP3K11,MAPK10,MAPK11,MAPK12,MAPK14,MEF2A,MKNK1,MYC,NFATC3,PDE9A,PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKAR1B,PRKCD,RALB,SMPDL3A,TNFSF10,TNFSF13,WNT16"
Necroptosis Signaling Pathway,1.58,2.5,0.102,"CAPN7,CASP1,CYBB,DAPK1,IRF9,MLKL,NLRP3,PLA2G4B,PYGL,RBCK1,RBL2,RIPK3,STAT2,TIMM9,TLR4,TNFSF10"
LPS-stimulated MAPK Signaling,1.62,2.333333333,0.122,"CD14,MAPK10,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,PRKCD,RALB,TLR4"
"Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis",1.63,,0.0955,"BMP6,BMPR1A,CALM1 (includes others),CSF1,CSF1R,FZD1,FZD2,IL1RN,IL7,ITGB1,LRP6,MAPK10,MAPK12,MAPK14,NFATC3,PIK3C2A,PIK3CD,SFRP2,SMAD1,TRAF6,WNT16"
Type II Diabetes Mellitus Signaling,1.64,1.133893419,0.106,"ACSL1,CACNA1F,CACNA2D4,CACNG6,IRS1,MAPK10,MAPK12,PIK3C2A,PIK3CD,PRKAA1,PRKCD,SLC27A3,SOCS2,SOCS3,SOCS5"
MSP-RON Signaling Pathway,1.67,,0.138,"CSF1,CSF2RB,F12,JAK2,PIK3C2A,PIK3CD,TLR2,TLR4"
fMLP Signaling in Neutrophils,1.67,0,0.112,"CALM1 (includes others),CYBB,FPR2,GNB2,GNB4,GNG2,NCF1,NFATC3,PIK3C2A,PIK3CD,PLCB1,PRKCD,RALB"
Role of JAK1 and JAK3 in ?c Cytokine Signaling,1.67,,0.13,"FES,IL4R,IL7,IRS1,JAK2,PIK3C2A,PIK3CD,RALB,SOCS3"
IL-17 Signaling,1.68,,0.125,"IL17RA,JAK2,MAPK10,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,RALB,TRAF6"
Apelin Endothelial Signaling Pathway,1.7,0.277350098,0.113,"ADCY1,CALM1 (includes others),GNAO1,HDAC4,MAPK10,MAPK12,MEF2A,PIK3C2A,PIK3CD,PLCB1,PRKAA1,PRKCD,RALB"
Acetate Conversion to Acetyl-CoA,1.7,,0.5,"ACSL1,ACSS2"
ILK Signaling,1.71,2.182820625,0.1,"ACTN1,CDH1,CREB5,DOCK1,IRS1,ITGB1,KRT18,LIMS2,MAPK10,MAPK12,MYC,MYH7B,MYL5,PARVB,PIK3C2A,PIK3CD,PPP2R3A,RHOBTB1,VEGFA"
PFKFB4 Signaling Pathway,1.73,1.889822365,0.152,"CREB5,FBP1,HK2,HK3,PFKFB4,PFKM,PRKAR1B"
G?i Signaling,1.76,1.732050808,0.112,"ADCY1,CNR1,FPR2,GNB2,GNB4,GNG2,HCAR2,OPRL1,PRKAR1B,RALB,RGS12,S1PR1,S1PR3,SSTR3"
Acute Myeloid Leukemia Signaling,1.77,-1,0.124,"CEBPA,CSF1R,CSF2RA,CSF2RB,CSF3R,MYC,PIK3C2A,PIK3CD,RALB,RARA,SPI1"
IL-17A Signaling in Fibroblasts,1.78,,0.171,"IL17RA,MAPK11,MAPK12,MAPK14,NFKBIZ,TRAF6"
GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells,1.78,1.386750491,0.116,"ADCY1,CACNA1F,CACNA2D4,CACNG6,FFAR2,GNA15,GNG2,GPBAR1,PLCB1,PLCD3,PRKAR1B,PRKCD,TAS1R3"
CCR3 Signaling in Eosinophils,1.79,1.414213562,0.113,"CALM1 (includes others),GNB2,GNB4,GNG2,LIMK2,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,PLA2G4B,PLCB1,PRKCD,RALB"
Eicosanoid Signaling,1.79,,0.136,"ALOX5,DPEP3,FPR2,PLA2G4B,PLAAT5,PTGDR,PTGER4,PTGS1,TBXAS1"
Hepatic Fibrosis / Hepatic Stellate Cell Activation,1.79,,0.102,"CCL5,CD14,COL18A1,COL6A6,COL9A2,CSF1,ECE1,IFNGR2,IGF1R,IGFBP3,IL4R,IL6R,MYH7B,MYL5,SERPINE1,SMAD7,TIMP2,TLR4,VEGFA"
Role of IL-17A in Arthritis,1.8,,0.145,"CCL5,IL17RA,MAPK10,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD"
Osteoarthritis Pathway,1.81,2.182820625,0.0995,"BMPR1A,CASP1,CASP4,CASP5,CREB5,EPAS1,FZD1,FZD2,HDAC4,ITGB1,PRKAA1,S100A8,S100A9,S1PR3,SDC4,SMAD1,SMAD7,TLR2,TLR4,VEGFA,WNT16"
Type I Diabetes Mellitus Signaling,1.81,1.897366596,0.117,"HLA-B,HLA-C,IFNGR2,JAK2,MAPK10,MAPK11,MAPK12,MAPK14,MYD88,SOCS2,SOCS3,SOCS5,TRAF6"
IL-17A Signaling in Airway Cells,1.83,1.414213562,0.138,"IL17RA,JAK2,MAPK10,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,TRAF6"
Apelin Pancreas Signaling Pathway,1.83,-1.889822365,0.159,"DDIT3,MAPK10,MAPK12,PIK3C2A,PIK3CD,PRKAA1,PRKAR1B"
Sperm Motility,1.83,0.707106781,0.0987,"CALM1 (includes others),CATSPER2,CSF1R,CSF2RA,EPHA1,EPHA2,EPHB2,FES,IGF1R,JAK2,LTK,LYN,MAP3K11,PLA2G4B,PLAAT5,PLCB1,PLCD3,PRKAR1B,PRKCD,RYK,TNK2,YES1"
Pathogenesis of Multiple Sclerosis,1.86,,0.333,"CCL3,CCL4,CCL5"
Fc?RIIB Signaling in B Lymphocytes,1.87,1.632993162,0.133,"CACNA1F,CACNA2D4,CACNG6,FCGR2B,LYN,MAPK10,MAPK12,PIK3C2A,PIK3CD,RALB"
IL-15 Production,1.87,2.672612419,0.116,"CSF1R,CSF2RA,EPHA1,EPHA2,EPHB2,FES,IGF1R,JAK2,LTK,LYN,MAP3K11,RYK,TNK2,YES1"
Thrombin Signaling,1.87,1.386750491,0.101,"ADCY1,ARHGEF11,ARHGEF5,F2RL3,GATA6,GNA15,GNAO1,GNB2,GNB4,GNG2,MAPK11,MAPK12,MAPK14,MYL5,PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKCD,RALB,RHOBTB1"
Corticotropin Releasing Hormone Signaling,1.88,0.832050294,0.11,"ADCY1,CACNA1F,CACNA2D4,CACNG6,CALM1 (includes others),CNR1,CREB5,GNAO1,MAPK11,MAPK12,MAPK14,MEF2A,POMC,PRKAR1B,PRKCD,VEGFA"
IL-22 Signaling,1.9,1,0.208,"MAPK10,MAPK11,MAPK12,MAPK14,SOCS3"
Endocannabinoid Cancer Inhibition Pathway,1.93,0,0.112,"ADCY1,CASP1,CASP4,CASP5,CDH1,CNR1,CREB5,DDIT3,GNAO1,MAPK14,MYC,PIK3C2A,PIK3CD,PRKAA1,PRKAR1B,VEGFA"
UVB-Induced MAPK Signaling,1.94,1.632993162,0.154,"H3-3A/H3-3B,MAPK10,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,PRKCD"
3-phosphoinositide Degradation,1.94,-0.727606875,0.11,"MTMR7,NUDT1,NUDT16,PDCD1,PP2D1,PPFIBP2,PPIP5K1,PPP1R16B,PPP2R3A,PTPN6,PTPN7,PXYLP1,SACM1L,SIRPA,SOCS3,SYNJ2,TNS3"
CXCR4 Signaling,1.95,1.941450687,0.108,"ADCY1,ARHGEF11,DOCK1,GNA15,GNAO1,GNB2,GNB4,GNG2,LYN,MAPK10,MAPK12,MYL5,PIK3C2A,PIK3CD,PLCB1,PRKCD,RALB,RHOBTB1"
NF-?B Signaling,1.96,2.064741605,0.106,"BMPR1A,IGF1R,IL1RN,IRAK3,IRAK4,LTBR,MYD88,PIK3C2A,PIK3CD,RALB,RELB,TLR2,TLR4,TLR5,TLR7,TLR8,TNFRSF17,TRAF6,UBE2N"
Renin-Angiotensin Signaling,1.96,2.309401077,0.119,"ADCY1,CCL5,JAK2,MAPK10,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,PRKAR1B,PRKCD,PTPN6,RALB,SHC3"
p38 MAPK Signaling,1.96,3.050851079,0.119,"CREB5,DDIT3,H3-3A/H3-3B,IL1RN,IRAK3,IRAK4,MAPK11,MAPK12,MAPK14,MEF2A,MKNK1,MYC,PLA2G4B,TRAF6"
"D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis",1.99,-1,0.113,"MTMR7,NUDT1,NUDT16,PDCD1,PP2D1,PPFIBP2,PPIP5K1,PPP1R16B,PPP2R3A,PTPN6,PTPN7,PXYLP1,SACM1L,SIRPA,SOCS3,TNS3"
"D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis",1.99,-1,0.113,"MTMR7,NUDT1,NUDT16,PDCD1,PP2D1,PPFIBP2,PPIP5K1,PPP1R16B,PPP2R3A,PTPN6,PTPN7,PXYLP1,SACM1L,SIRPA,SOCS3,TNS3"
Role of PKR in Interferon Induction and Antiviral Response,1.99,1.941450687,0.12,"CASP1,CASP5,HSPA1A/HSPA1B,HSPA6,IFNGR2,IRF9,MAPK10,MAPK11,MAPK12,MAPK14,MYD88,STAT2,TLR4,TRAF6"
B Cell Activating Factor Signaling,1.99,0.816496581,0.171,"MAPK10,MAPK11,MAPK12,MAPK14,NFATC3,TNFRSF17,TRAF6"
3-phosphoinositide Biosynthesis,2,-0.942809042,0.109,"MTMR7,NUDT1,NUDT16,PDCD1,PIK3C2A,PIK3CD,PP2D1,PPFIBP2,PPIP5K1,PPP1R16B,PPP2R3A,PTPN6,PTPN7,PXYLP1,SACM1L,SIRPA,SOCS3,TNS3"
Cardiac Hypertrophy Signaling,2.02,1.605910137,0.1,"ADCY1,CALM1 (includes others),GNA15,GNAO1,GNB2,GNB4,GNG2,IGF1R,IL6R,IRS1,MAP3K11,MAPK10,MAPK11,MAPK12,MAPK14,MEF2A,MYL5,PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKAR1B,RALB,RHOBTB1"
Salvage Pathways of Pyrimidine Deoxyribonucleotides,2.02,,0.375,"APOBEC3A,TK1,TYMP"
Endocannabinoid Developing Neuron Pathway,2.06,1.154700538,0.122,"ADCY1,CNR1,CREB5,GNAO1,GNG2,MAPK10,MAPK11,MAPK12,MAPK14,MGLL,PIK3C2A,PIK3CD,PRKAR1B,RALB"
Prolactin Signaling,2.06,2.110579412,0.136,"IRS1,JAK2,MYC,PIK3C2A,PIK3CD,PRKCD,PRLR,RALB,SOCS2,SOCS3,SOCS5"
Superpathway of Inositol Phosphate Compounds,2.1,-1.091089451,0.106,"MTMR7,NUDT1,NUDT16,PDCD1,PIK3C2A,PIK3CD,PLCB1,PLCD3,PP2D1,PPFIBP2,PPIP5K1,PPP1R16B,PPP2R3A,PTPN6,PTPN7,PXYLP1,SACM1L,SIRPA,SOCS3,SYNJ2,TNS3"
Glycogen Degradation III,2.1,1,0.286,"MGAM,PGM5,PYGL,TYMP"
IL-10 Signaling,2.11,,0.145,"CD14,FCGR2B,HMOX1,IL1RN,IL4R,MAPK11,MAPK12,MAPK14,SOCS3,TRAF6"
B Cell Receptor Signaling,2.12,1.885618083,0.108,"BCL2A1,BCL6,CALM1 (includes others),CREB5,DAPP1,FCGR2B,GAB2,LYN,MAP3K11,MAPK11,MAPK12,MAPK14,NFATC3,PIK3AP1,PIK3C2A,PIK3CD,PTPN6,RALB,SYNJ2,VAV2"
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis,2.14,,0.133,"CSF1,HLA-B,IL1RN,IL23A,RELB,TLR2,TLR4,TLR5,TLR7,TLR8,TNFRSF17,TNFSF13"
Rac Signaling,2.16,1.386750491,0.125,"ABI2,ARFIP2,BAIAP2,CYBB,CYFIP1,ELK4,ITGB1,LIMK2,MAP3K11,NCF1,PIK3C2A,PIK3CD,RALB,TIAM1"
G-Protein Coupled Receptor Signaling,2.16,,0.0993,"ADCY1,ADORA2B,CHRM5,CNR1,CREB5,FPR2,GNA15,GNAO1,GPER1,HCAR2,HCAR3,HRH2,OPRL1,PDE9A,PIK3C2A,PIK3CD,PLCB1,PRKAR1B,PTGDR,PTGER4,RALB,RGS12,S1PR1,S1PR3,SMPDL3A,SSTR3,VIPR1"
Trehalose Degradation II (Trehalase),2.2,,0.429,"HK2,HK3,HKDC1"
Signaling by Rho Family GTPases,2.21,2.828427125,0.102,"ARFIP2,ARHGEF11,ARHGEF5,BAIAP2,CDH1,CDH23,CDH26,CYBB,CYFIP1,GNA15,GNAO1,GNB2,GNB4,GNG2,ITGB1,LIMK2,MAP3K11,MAPK10,MAPK12,MYL5,NCF1,PIK3C2A,PIK3CD,RHOBTB1,SEPTIN4"
UDP-N-acetyl-D-galactosamine Biosynthesis II,2.23,,0.308,"GNPDA2,HK2,HK3,HKDC1"
D-myo-inositol-5-phosphate Metabolism,2.24,-1.414213562,0.115,"MTMR7,NUDT1,NUDT16,PDCD1,PLCB1,PLCD3,PP2D1,PPFIBP2,PPIP5K1,PPP1R16B,PPP2R3A,PTPN6,PTPN7,PXYLP1,SACM1L,SIRPA,SOCS3,TNS3"
IL-12 Signaling and Production in Macrophages,2.26,,0.121,"IL23A,IL23R,MAPK10,MAPK11,MAPK12,MAPK14,MYD88,ORM2,PIK3C2A,PIK3CD,PRKCD,S100A8,SPI1,TLR2,TLR4,TRAF6"
Antioxidant Action of Vitamin C,2.26,-2.110579412,0.128,"CSF2RA,CSF2RB,HMOX1,JAK2,MAPK10,MAPK11,MAPK12,MAPK14,PLA2G4B,PLAAT5,PLCB1,PLCD3,PLD3,SLC2A3"
Acute Phase Response Signaling,2.27,2.672612419,0.112,"C2,HMOX1,HP,IL1RN,IL6R,ITIH4,JAK2,MAPK11,MAPK12,MAPK14,MYD88,ORM2,PIK3CD,RALB,SERPINE1,SERPING1,SOCS2,SOCS3,SOCS5,TRAF6"
cAMP-mediated signaling,2.28,1.04257207,0.105,"ADCY1,ADORA2B,AKAP5,CALM1 (includes others),CHRM5,CNR1,CREB5,FPR2,GNAO1,GPER1,HCAR2,HCAR3,HRH2,OPRL1,PDE9A,PRKAR1B,PTGDR,PTGER4,RGS12,S1PR1,S1PR3,SMPDL3A,SSTR3,VIPR1"
Communication between Innate and Adaptive Immune Cells,2.33,,0.135,"CCL3,CCL4,CCL5,HLA-B,HLA-C,IL1RN,TLR2,TLR4,TLR5,TLR7,TLR8,TNFRSF17,TNFSF13"
IL-4 Signaling,2.34,,0.141,"HLA-B,IL13RA1,IL4R,IRF4,IRS1,JAK2,NFATC3,PIK3C2A,PIK3CD,PTPN6,RALB,SYNJ2"
Tec Kinase Signaling,2.36,1.732050808,0.116,"GNA15,GNAO1,GNB2,GNB4,GNG2,ITGB1,JAK2,LYN,MAPK10,MAPK12,PIK3C2A,PIK3CD,PRKCD,RHOBTB1,STAT2,TLR4,TNFSF10,VAV2,YES1"
Glucose and Glucose-1-phosphate Degradation,2.37,,0.333,"HK2,HK3,HKDC1,PGM5"
IL-23 Signaling Pathway,2.38,0.707106781,0.182,"IL23A,IL23R,JAK2,PIK3C2A,PIK3CD,RORA,RORC,SOCS3"
Endocannabinoid Neuronal Synapse Pathway,2.39,1.069044968,0.125,"ADCY1,CACNA1F,CACNA2D4,CACNG6,CNR1,GNA15,GNAO1,GNG2,MAPK10,MAPK11,MAPK12,MAPK14,MGLL,PLCB1,PLCD3,PRKAR1B"
Axonal Guidance Signaling,2.41,,0.0909,"ADAM12,ADAM15,ADAM19,ADAM9,ADAMTS17,ARHGEF11,BAIAP2,BMP6,DOCK1,EPHA1,EPHA2,EPHB2,FES,FZD1,FZD2,GDF7,GNA15,GNAO1,GNB2,GNB4,GNG2,ITGB1,LIMK2,MKNK1,MMP25,MYL5,NFATC3,NTNG2,PIK3C2A,PIK3CD,PLCB1,PLCD3,PLXNB2,PLXNC1,PRKAR1B,PRKCD,RALB,SEMA4A,SEMA4B,TUBA1A,TUBA1C,UNC5A,VEGFA,WNT16"
Factors Promoting Cardiogenesis in Vertebrates,2.42,1.697749375,0.12,"ACVR1,ACVR1B,BMP6,BMPR1A,CREB5,FZD1,FZD2,LRP6,MAPK10,MAPK12,MAPK14,MYC,NODAL,PLCB1,PLCD3,PRKCD,SMAD1,WNT16"
Mouse Embryonic Stem Cell Pluripotency,2.48,2.496150883,0.136,"BMPR1A,FZD1,FZD2,ID2,ID3,JAK2,MAPK11,MAPK12,MAPK14,MYC,PIK3C2A,PIK3CD,RALB,SMAD1"
IL-6 Signaling,2.49,1.603567451,0.128,"ABCB1,CD14,IL1RN,IL6R,JAK2,MAPK10,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,RALB,SOCS3,TNFAIP6,TRAF6,VEGFA"
Phagosome Formation,2.49,,0.128,"C3AR1,CLEC7A,CR1,FCGR2B,ITGB1,PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKCD,RHOBTB1,TLR2,TLR4,TLR5,TLR7,TLR8"
Th2 Pathway,2.5,1.069044968,0.125,"ACVR1,ACVR1B,GFI1,HLA-B,HLA-DPB1,HLA-DQA2,ICOSLG/LOC102723996,IL4R,JAG2,JAK2,NOTCH4,PIK3C2A,PIK3CD,S1PR1,SOCS3,SPI1,TNFRSF4"
IL-17A Signaling in Gastric Cells,2.52,2,0.24,"CCL5,IL17RA,MAPK10,MAPK11,MAPK12,MAPK14"
GDP-glucose Biosynthesis,2.52,,0.364,"HK2,HK3,HKDC1,PGM5"
RAR Activation,2.52,,0.113,"ADCY1,CSF2RB,HLTF,IGFBP3,JAK2,MAPK10,MAPK11,MAPK12,MAPK14,PHF10,PIK3CD,PRKAR1B,PRKCD,RARA,RDH10,RELB,SMAD1,SMAD7,SMARCD3,SORBS3,TRIM24,VEGFA"
Role of NFAT in Cardiac Hypertrophy,2.64,1.788854382,0.112,"ADCY1,AKAP5,CACNA1F,CACNA2D4,CACNG6,CALM1 (includes others),GNB2,GNB4,GNG2,HDAC4,IGF1R,MAPK10,MAPK11,MAPK12,MAPK14,MEF2A,PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKAR1B,PRKCD,RALB,SLC8A1"
IL-8 Signaling,2.69,2.667891875,0.115,"ARRB2,CDH1,CXCR1,CYBB,GNB2,GNB4,GNG2,HMOX1,IRAK3,IRAK4,LIMK2,MAPK10,MAPK12,NCF1,PIK3C2A,PIK3CD,PLD3,PRKCD,RAB11FIP2,RALB,RHOBTB1,TRAF6,VEGFA"
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages,2.69,3.771236166,0.117,"CYBB,IFNGR2,JAK2,MAP3K11,MAPK10,MAPK11,MAPK12,MAPK14,NCF1,NCF4,ORM2,PIK3C2A,PIK3CD,PPP2R3A,PRKCD,PTPN6,RHOBTB1,S100A8,SIRPA,SPI1,TLR2,TLR4"
April Mediated Signaling,2.73,1.133893419,0.205,"MAPK10,MAPK11,MAPK12,MAPK14,NFATC3,TNFRSF17,TNFSF13,TRAF6"
TGF-? Signaling,2.77,1.732050808,0.146,"ACVR1,ACVR1B,BMPR1A,IRF7,MAPK11,MAPK12,MAPK14,NODAL,RALB,SERPINE1,SMAD1,SMAD7,SMURF2,TRAF6"
Natural Killer Cell Signaling,2.78,1.459600898,0.117,"COL18A1,HLA-B,HLA-C,HSPA1A/HSPA1B,HSPA6,IRAK4,ITGB1,JAK2,KIR3DL2,LIMK2,MAP3K11,MAPK11,MAPK12,MAPK14,MYD88,NFATC3,PIK3C2A,PIK3CD,PTPN6,RALB,TNFSF10,TRAF6,VAV2"
Role of Tissue Factor in Cancer,2.79,,0.137,"ARRB2,CSF1,GNA15,ITGB1,JAK2,LIMK2,LYN,MAPK11,MAPK12,MAPK14,PIK3C2A,PIK3CD,PLCB1,RALB,VEGFA,YES1"
Th1 and Th2 Activation Pathway,2.86,,0.123,"ACVR1,ACVR1B,GFI1,HLA-B,HLA-DPB1,HLA-DQA2,ICOSLG/LOC102723996,IFNGR2,IL27,IL4R,IL6R,JAG2,JAK2,NFATC3,NOTCH4,PIK3C2A,PIK3CD,S1PR1,SOCS3,SPI1,TNFRSF4"
Complement System,2.88,-0.816496581,0.216,"C2,C3AR1,CD55,CD59,CFH,CR1,MASP2,SERPING1"
Colorectal Cancer Metastasis Signaling,2.89,2.857738033,0.111,"ADCY1,BIRC5,CDH1,FZD1,FZD2,GNB2,GNB4,GNG2,IL6R,JAK2,LRP6,MAPK10,MAPK12,MMP25,MYC,PIK3C2A,PIK3CD,PRKAR1B,PTGER4,RALB,RHOBTB1,TLR2,TLR4,TLR5,TLR7,TLR8,VEGFA,WNT16"
AMPK Signaling,2.97,1.5,0.117,"CHRM5,CHRNA2,CHRNB2,CHRNE,CREB5,HLTF,IRS1,MAPK11,MAPK12,MAPK14,PCK2,PFKFB2,PFKFB3,PFKFB4,PFKM,PHF10,PIK3C2A,PIK3CD,PPM1E,PPP2R3A,PRKAA1,PRKAR1B,RAB9B,SMARCD3,ULK1"
Th17 Activation Pathway,3,2.138089935,0.154,"IL23A,IL23R,IL6R,IRAK3,IRAK4,IRF4,JAK2,MYD88,NFATC3,PTGER4,RORA,RORC,SOCS3,TRAF6"
Growth Hormone Signaling,3.02,0.904534034,0.169,"CEBPA,IGF1R,IGFBP3,IRS1,JAK2,PIK3C2A,PIK3CD,PRKCD,PTPN6,SOCS2,SOCS3,SOCS5"
Inflammasome pathway,3.07,2.449489743,0.3,"AIM2,CASP1,CASP5,MYD88,NLRP3,TLR4"
T Cell Exhaustion Signaling Pathway,3.1,1.290994449,0.126,"ACVR1,ACVR1B,BCL6,HLA-B,HLA-C,HLA-DPB1,HLA-DQA2,IL6R,IRF4,IRF9,JAK2,MAPK10,MAPK12,NFATC3,PDCD1,PIK3C2A,PIK3CD,PPP2R3A,PTPN6,RALB,STAT2,VEGFA"
Hepatic Fibrosis Signaling Pathway,3.12,2.873524466,0.103,"ACVR1,ACVR1B,CALM1 (includes others),CCL3,CCL5,CNR1,COL18A1,CREB5,CYBB,FZD1,FZD2,IL17RA,IL1RN,IRAK3,IRAK4,ITGB1,JAK2,LRP6,MAPK10,MAPK11,MAPK12,MAPK14,MYC,MYD88,MYL5,NCF1,PIK3C2A,PIK3CD,PRKAR1B,PRKCD,RALB,RHOBTB1,SERPINE1,SMAD7,TLR4,TRAF6,VEGFA,WNT16"
G?s Signaling,3.21,0.534522484,0.15,"ADCY1,ADORA2B,CHRM5,CNR1,CREB5,GNB2,GNB4,GNG2,GPER1,HCAR2,HCAR3,HRH2,PRKAR1B,PTGDR,PTGER4,VIPR1"
Role of JAK family kinases in IL-6-type Cytokine Signaling,3.3,,0.28,"IL6R,JAK2,MAPK10,MAPK11,MAPK12,MAPK14,SOCS3"
CCR5 Signaling in Macrophages,3.35,0.707106781,0.16,"CACNA1F,CACNA2D4,CACNG6,CALM1 (includes others),CCL3,CCL4,CCL5,GNB2,GNB4,GNG2,MAPK10,MAPK11,MAPK12,MAPK14,PRKCD"
Endothelin-1 Signaling,3.43,2.836832573,0.128,"ADCY1,CASP1,CASP4,CASP5,ECE1,GNA15,GNAO1,HMOX1,MAPK10,MAPK11,MAPK12,MAPK14,MYC,PIK3C2A,PIK3CD,PLA2G4B,PLAAT5,PLCB1,PLCD3,PLD3,PRKCD,PTGS1,RALB,SHC3"
IL-1 Signaling,3.51,2.121320344,0.165,"ADCY1,GNA15,GNAO1,GNB2,GNB4,GNG2,IRAK3,IRAK4,MAPK10,MAPK11,MAPK12,MAPK14,MYD88,PRKAR1B,TRAF6"
Dendritic Cell Maturation,3.6,2.400396793,0.131,"COL18A1,CREB5,FCGR2B,HLA-B,HLA-C,IL1RN,IL23A,JAK2,LTBR,LY75,MAPK10,MAPK11,MAPK12,MAPK14,MYD88,PIK3C2A,PIK3CD,PLCB1,PLCD3,RELB,STAT2,TLR2,TLR4,TRAF6"
Toll-like Receptor Signaling,3.83,2.886751346,0.184,"CD14,IL1RN,IRAK3,IRAK4,MAPK11,MAPK12,MAPK14,MYD88,TLR2,TLR4,TLR5,TLR7,TLR8,TRAF6"
Systemic Lupus Erythematosus In B Cell Signaling Pathway,3.95,1.566698904,0.12,"CALM1 (includes others),FCGR2B,IFIT2,IFIT3,IFNGR2,IL6R,IRAK4,IRF5,IRF7,IRF9,JAK2,LILRB3,LILRB4,LYN,MYC,MYD88,NFATC3,PDCD1,PIK3AP1,PIK3C2A,PIK3CD,PRKCD,PTPN6,RALB,SHC3,STAT2,SYNJ2,TLR7,TLR8,TNFSF10,TNFSF13,TRAF6,YES1"
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses,4.34,2.5,0.149,"C3AR1,CASP1,CCL5,CLEC6A,CLEC7A,IRF7,MAPK10,MAPK12,MYD88,NLRP3,OAS1,OAS3,PIK3C2A,PIK3CD,PRKCD,TLR2,TLR4,TLR5,TLR7,TLR8,TNFSF10,TNFSF13,TRAF6"
Interferon Signaling,4.46,3,0.278,"IFI35,IFI6,IFIT1,IFIT3,IFITM3,IFNGR2,IRF9,JAK2,OAS1,STAT2"
Role of JAK2 in Hormone-like Cytokine Signaling,4.7,,0.294,"HLTF,IRS1,JAK2,PRLR,PTPN6,SH2B2,SIRPA,SOCS2,SOCS3,SOCS5"
STAT3 Pathway,4.78,2.667891875,0.163,"BMP6,BMPR1A,CSF2RB,CXCR1,IGF1R,IL13RA1,IL17RA,IL4R,IL6R,JAK2,MAP3K11,MAPK10,MAPK11,MAPK12,MAPK14,MYC,PTPN6,RALB,SOCS2,SOCS3,SOCS5,VEGFA"
"Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis",4.96,,0.125,"CALM1 (includes others),CCL5,CEBPA,CREB5,CSF1,FZD1,FZD2,GNAO1,IL17RA,IL1RN,IL6R,IL7,IRAK3,IRAK4,JAK2,LRP6,LTBR,MAPK14,MYC,MYD88,NFATC3,PIK3C2A,PIK3CD,PLCB1,PLCD3,PRKCD,PRSS1,RALB,RYK,SFRP2,SOCS3,TLR2,TLR4,TLR5,TLR7,TLR8,TRAF6,VEGFA,WNT16"
Neuroinflammation Signaling Pathway,4.98,3.666666667,0.127,"ACVR1,ACVR1B,APP,BIRC5,CALB1,CASP1,CCL3,CCL5,CREB5,CSF1R,CYBB,FZD1,HLA-B,HLA-C,HMOX1,IFNGR2,IL6R,IRAK3,IRAK4,IRF7,JAK2,MAPK10,MAPK11,MAPK12,MAPK14,MYD88,NCF1,NFATC3,NLRP3,PIK3C2A,PIK3CD,PLA2G4B,TLR2,TLR4,TLR5,TLR7,TLR8,TRAF6"
iNOS Signaling,5.04,2.529822128,0.267,"CALM1 (includes others),CD14,IFNGR2,IRAK3,IRAK4,JAK2,MAPK11,MAPK12,MAPK14,MYD88,TLR4,TRAF6"
TREM1 Signaling,5.13,3,0.213,"CASP1,CASP5,CCL3,FCGR2B,ITGB1,JAK2,LAT2,MYD88,NLRP12,NLRP3,NLRP6,TLR2,TLR4,TLR5,TLR7,TLR8"
